Demant

Demant sells Oticon Medical to Impilo, sharpening focus on core hearing‑aid tech, boosting margins and investor confidence while keeping implantable devices safe and available.

Demant A/S’s March 2026 AGM shows steady hearing‑care strategy, resilient margins, and tech‑driven growth amid Nordic market pullbacks.

Demant’s March 5 AGM shows no new moves, keeping its Danish C25 role steady—short‑sellers see limited upside, yet the company remains a stable investment choice.

Demant, a Danish leader in hearing-care and vision-care solutions, is making strategic moves to expand its market position, including a significant investment in Invisio and a merger-control procedure to acquire KIND and audifon, while navigating th…